Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › IDXX Leadership & Pay · Oct 7, 2025
Effective October 6, 2025, IDEXX Laboratories, Inc. elected Karen Peacock as an independent Class I Director… IDXX Idexx Laboratories Inc
Effective October 6, 2025, IDEXX Laboratories, Inc. elected Karen Peacock as an independent Class I Director, increasing the total number of directors from ten to eleven. Ms. Peacock will also serve as a member of the company's Compensation and Talent Committee and Finance Committee.
More from Idexx Laboratories Inc IDEXX raises 2026 EPS outlook to $14.96-$15.16 and revenue guidance to $4.74B-$4.77B Nov 2, 2026 IDEXX Laboratories reported second quarter 2026 revenue of $1,217 million, a 10% increase as reported and 9% organic… Aug 4, 2026 IDEXX Laboratories shareholders approved amendments to declassify the Board of Directors over a three-year period and… May 15, 2026 IDEXX Laboratories, Inc. announced its financial results for the first quarter ended March 31, 2026 May 5, 2026 IDEXX Laboratories announced that Nimrata Hunt, PhD, Executive Vice President, Global Strategy and Commercial, will… Mar 26, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
